1) Portal hypertensive colopathy
门脉高压性结肠病
1.
Objective:To observe the therapeutic action and study the mechanism of angiotonin AT1 receptor blorcker losartan in rats with portal hypertensive colopathy(PHC).
目的:探讨门脉高压性结肠病(PHC)的发病机制和血管紧张素AT1型受体拮抗剂氯沙坦对PHC的治疗作用及其治疗机制;探索氯沙坦在门脉高压时对结肠高动力循环血流动力学的改善和对结肠黏膜的保护作用。
2) Portal hypertensive colonopathy
门脉高压性肠病
3) portal hypertensive enteropathy
门静脉高压性肠病
1.
Portal hypertensive enteropathy,whose fundamental pathologic change is a vasculopathy characterized histopathologically by mucosal and submucosal vessel dilatation,oedema and congestion,mainly results from a combination of increased intrahepatic vascular resistance and increased blood flow through the portal venous system.
肝硬化门静脉高压性肠病(portal hypertensive enteropathy,PHE)的2大主要发病机制是肝内门脉血流阻力增加和流经门脉血流增多。
4) Gastrointestinal haemodynamic
门脉高压性胃肠病
5) portal hypertensive gastropathy
门脉高压性胃病
1.
Clinical analysis on portal hypertensive gastropathy treated with omeprazole;
奥美拉唑治疗门脉高压性胃病的临床研究
2.
Effect of losartan on portal hypertensive gastropathy in rats;
洛沙坦在大鼠门脉高压性胃病中的作用
3.
Gastroscopy and analysis of portal hypertensive gastropathy in the patients with hepatocirrhosis;
肝硬化患者门脉高压性胃病的胃镜检查与分析
6) Portal hypertensive biliopathy
门脉高压性胆病
1.
Portal hypertensive biliopathy (PHB) refers to abnormalities of the entire biliary tract including intrahepatic and extrahepatic bile ducts, cystic duct and gallbladder in patients with portal hy-pertension.
门脉高压性胆病(PHB)为继发于门静脉高压特别是肝外门静脉阻塞患者的肝内、外胆管和/或胆囊壁、胆囊管的异常改变。
补充资料：门脉高压症
门脉高压症
系指肝脏门静脉系统压力升高，主要由于肝内正常结构被改建，血流阻力增高引起，常见于肝硬化。门脉压升高以后，胃、肠和脾等器官的静脉血回流受阻，早期因代偿可无明显症状，晚期常表现为脾肿大和脾功能亢进，胃肠道瘀血，腹水，侧支循环的建立与开放。如果食管静脉丛发生破裂，可引起呕血、黑便。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条